SS-31 (elamipretide) he peptide liʻiliʻi-mole me ʻehā nā ʻakika amino; kikoʻī kikoʻī mitochondria.
Ke komo pono o nā membrane cell ʻo ia kekahi o kāna mau hiʻohiʻona nui, me ka pahu hopu pololei o ka membrane mitochondrial i loko.
ʻAʻole hiki i nā antioxidants kuʻuna ke hōʻiliʻili pono i loko o ka mea paʻa matrix mitochondrial, hoʻomākaʻi ʻana ʻano oxygen reactive (ROS) ma ke ano he kaohi nui.
ʻO ka hoʻolālā kūʻokoʻa o SS-31 e ʻae i ka neutralization o nā radical manuahi, a me nā ʻano like ʻole nā pilina electrostatic/nā pilina hydrophobic; ʻO ka heleuma kikoʻī i ka mitochondria iā ia iho he hopena pololei o kēia.
ʻIke ʻia ka lāʻau lapaʻau Mitochondrial holoʻokoʻa i ka SS-31 ʻo ia kekahi o nā lāʻau lapaʻau kokoke loa e hiki mai ana..
Ma waho aʻe o nā hopena cytoprotective, ʻike ʻia nā hana hoʻoponopono ikaika.
ʻO ka uhaki ʻana i ka pōʻai ʻino ʻino mua o ke koʻikoʻi oxidative ka mea e hoʻokaʻawale ai iā SS-31.
Hoʻomaikaʻi i ka myocardial ikehu metabolism, liʻiliʻi liʻiliʻi infarct nui, ka hana puʻuwai holoʻokoʻa, a i kekahi manawa, hana neurodegenerative, hiki i na mea a pau.
ʻO ka hoʻomanawanui hoʻoikaika kino a me ka ikaika o ka ʻiʻo, he mea nui nae, nā hopena i hiki iā SS-31 ke hoʻoikaika.
Kaʻina
D-Arg-Dmt-Lys-Phe-NH2; Dmt=2',6'-dimethylTyr
Helu CAS
736992-21-5
ʻĀpana Molekala
C32H49N9O5
Kaumaha Molekala
639.8 g/mol
Imi No SS-31
1.Nā noi lāʻau lapaʻau a me ka hiki ke hoʻōla
Ua hōʻike nā hoʻokolohua lapaʻau mua i nā hopena cytoprotective koʻikoʻi – nā myopathies mitochondrial mua, ʻO Barth syndrome, puʻuwai hāʻule, ʻeha ʻeha ʻeha a me ka ma'i maka malo'o e hō'ike ana i nā wahi maika'i o ka ho'ohana 'ana i ka lā'au lapa'au.
2.Nā hopena antioxidant
Hoʻolaha nui ʻia nā antioxidants maʻamau akā e like me ka mea i ʻōlelo ʻia ma luna nei, ʻaʻole i komo i loko.
Hiki i nā waiwai physicochemical o SS-31 ke hiki i ka hōʻiliʻili koho nui.
ʻO ka hāʻawi electron (dimethyltyrosine) pili pono a hoʻopau i nā radical manuahi i hana ʻia i loko o ka kaulahao lawe electron.
ʻO ka hoʻopau ʻana i ka pae kumu o ke koʻikoʻi oxidative ka pahuhopu kumu; palekana o DNA mitochondrial, mau (maikaʻi loa) mālama i ka microenvironment, a me ka mea nui, hana ikehu ola, ʻo ia ka hopena o nā mea a pau i luna.
Hoʻolohi a hoʻopaneʻe paha i nā kaʻina hana ʻelemakule a me kahi ākea o nā maʻi hiki ʻole ke hoʻōla ʻia ma mua, ʻo ia nā pahuhopu hope o kēia laina noiʻi.
3.Hoʻomaikaʻi i ke kūlana ikehu ʻōnaehana i hoʻopilikia ʻia e ka maʻi kanesa a me ka chemotherapy
I ka ʻiʻo iwi o nā maʻi maʻi maʻi, ʻO ka mitochondrial dysfunction ke kumu nui o ka emi ʻana Hoʻohui ATP; ʻO ka atrophy ʻiʻo hiki ʻole ke hoʻololi ʻia a me ka deformation ma hope mai e like me ka hopena pololei.
Hoʻopau maikaʻi ʻo SS-31 cachexia, pale i ka hōʻemi ʻana i ka wahi o ka fiber muscle glycolytic, poloka i ka poho mitochondrial a me nā ʻano like ʻole autophagy/mitosis.
ʻIkepili o ka ʻiʻo iwi, ate, a me nā metabolites plasma e hōʻike ana i nā loli nui i ka ikehu a me ka protein metabolism i loko o ka pūʻali maʻi tumora.
4.Ka hoʻomaikaʻi ʻana i ka mitochondrial dysfunction a me ka hōʻino hoʻomanaʻo pili
Endotoxin-Hōʻike nā ʻiole i mālama ʻia i nā ʻano āpau o kēia dysfunction mitochondrial – kaumaha oxidative, nā pane inflammatory, apoptosis neuronal, kuamoʻo dendritic hippocampal poho – ke aʻo a me nā mana hoʻomanaʻo maʻalahi e like me ka hopena.
Hōʻike nā hoʻokolohua i nā hopena pale o SS-31 i nā mea i haʻi mua ʻia; modulation o ʻO ke kumu neurotrophic no ka lolo, aiʻole aneurin BDNF hōʻailona ma ke ʻano he ala kī.
ʻO ka hoʻihoʻi ʻana o kekahi mau hoʻololi protein hōʻailona synaptic a hoʻonui (physiological) ʻike ʻia ka paʻakikī o nā synapses.
Hiki i ka lāʻau lapaʻau no ke kaumaha oxidative/neuroinflammation ʻike ʻia ke ʻano pōʻino.
5.Kāohi i ka mitochondrial permeability transition pore (mPTP) wehe ʻia e pale i ka apoptosis
Mālama ʻo SS-31 i ka pono o ka membrane mitochondrial i loko, ma o nā hopena antioxidant a me nā hopena synthesis ATP paʻa.
Hana pololei ma adenine nucleotide translocator (ANT) hoʻokuke i ka paepae no mitochondrial permeability transition pore /mPTP wehe ana.
Hoʻopau maikaʻi ʻia ka hoʻōla mua ʻana o kēia kaʻina hana; nā kūlana koʻikoʻi (hōʻeha o ka myocardial, hahau e like me na hihia hoike) hiki ke mālama ʻia ma ka liʻiliʻi loa e kēia laina o ka inhibition.
6.Kāohi ʻana i kahi pane ʻāhu
Hoʻopili ʻia nā mea a pau i luna.
Hoʻomaikaʻi ʻia ka hana Mitochondrial, hoemiia ka poino, a ʻo nā hopena a pau o lalo o ka ʻaʻa maʻi a i ʻole ka maʻi ʻeha e hoʻemi iki ʻia.
Aia ka waiwai therapeutic piha o SS-31 i kēia mau hui, nae kumu, nā hana anti-inflammatory.
COA
HPLC
MS





